U.S. Markets closed

Global Antibiotics Industry

Antibiotics market worldwide is projected to grow by US$7. 2 Billion, driven by a compounded growth of 2. 3%. Beta Lactam & Beta Lactamase Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.

New York, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Antibiotics Industry" - https://www.reportlinker.com/p05817707/?utm_source=GNW
7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$20.5 Billion by the year 2025, Beta Lactam & Beta Lactamase Inhibitors will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$282 Million to the region’s size and clout in the next 5 to 6 years. Over US$212.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Beta Lactam & Beta Lactamase Inhibitors will reach a market size of US$1.2 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.7% over the next couple of years and add approximately US$2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Abbott Laboratories, Inc.; Allergan PLC; Aurobindo Pharma Ltd.; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Lupin Pharmaceuticals, Inc.; Merck & Co., Inc.; Mylan NV; Novartis International AG; Pfizer, Inc.; Sanofi; Shionogi, Inc.; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05817707/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Antibiotics Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Antibiotics Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2018-2025
Table 2: Antibiotics Global Retrospective Market Scenario in
US$ Million by Region/Country: 2009-2017
Table 3: Antibiotics Market Share Shift across Key Geographies
Worldwide: 2009 VS 2019 VS 2025
Table 4: Beta Lactam & Beta Lactamase Inhibitors (Drug Class)
World Market by Region/Country in US$ Million: 2018 to 2025
Table 5: Beta Lactam & Beta Lactamase Inhibitors (Drug Class)
Historic Market Analysis by Region/Country in US$ Million: 2009
to 2017
Table 6: Beta Lactam & Beta Lactamase Inhibitors (Drug Class)
Market Share Breakdown of Worldwide Sales by Region/Country:
2009 VS 2019 VS 2025
Table 7: Quinolone (Drug Class) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Quinolone (Drug Class) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Quinolone (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Macrolide (Drug Class) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Macrolide (Drug Class) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Macrolide (Drug Class) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Other Classes (Drug Class) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Other Classes (Drug Class) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Other Classes (Drug Class) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Natural (Drug Origin) World Market by Region/Country
in US$ Million: 2018 to 2025
Table 17: Natural (Drug Origin) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Natural (Drug Origin) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Semisynthetic (Drug Origin) World Market Estimates
and Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Semisynthetic (Drug Origin) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Semisynthetic (Drug Origin) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Synthetic (Drug Origin) Market Opportunity Analysis
Worldwide in US$ Million by Region/Country: 2018 to 2025
Table 23: Synthetic (Drug Origin) Global Historic Demand in US$
Million by Region/Country: 2009 to 2017
Table 24: Synthetic (Drug Origin) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Oral (Route of Administration) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Oral (Route of Administration) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 27: Oral (Route of Administration) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Intravenous (Route of Administration) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 29: Intravenous (Route of Administration) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 30: Intravenous (Route of Administration) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 31: Other Route of Administrations (Route of
Administration) Geographic Market Spread Worldwide in US$
Million: 2018 to 2025
Table 32: Other Route of Administrations (Route of
Administration) Region Wise Breakdown of Global Historic Demand
in US$ Million: 2009 to 2017
Table 33: Other Route of Administrations (Route of
Administration) Market Share Distribution in Percentage by
Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Antibiotics Market Share (in %) by Company: 2019 & 2025
Table 34: United States Antibiotics Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 35: Antibiotics Market in the United States by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 36: United States Antibiotics Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
Table 37: United States Antibiotics Market Estimates and
Projections in US$ Million by Drug Origin: 2018 to 2025
Table 38: Antibiotics Market in the United States by Drug
Origin: A Historic Review in US$ Million for 2009-2017
Table 39: United States Antibiotics Market Share Breakdown by
Drug Origin: 2009 VS 2019 VS 2025
Table 40: United States Antibiotics Market Estimates and
Projections in US$ Million by Route of Administration: 2018 to
2025
Table 41: Antibiotics Market in the United States by Route of
Administration: A Historic Review in US$ Million for 2009-2017
Table 42: United States Antibiotics Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
CANADA
Table 43: Canadian Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Class: 2018 to 2025
Table 44: Canadian Antibiotics Historic Market Review by Drug
Class in US$ Million: 2009-2017
Table 45: Antibiotics Market in Canada: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Table 46: Canadian Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Origin: 2018 to 2025
Table 47: Canadian Antibiotics Historic Market Review by Drug
Origin in US$ Million: 2009-2017
Table 48: Antibiotics Market in Canada: Percentage Share
Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
Table 49: Canadian Antibiotics Market Estimates and Forecasts
in US$ Million by Route of Administration: 2018 to 2025
Table 50: Canadian Antibiotics Historic Market Review by Route
of Administration in US$ Million: 2009-2017
Table 51: Antibiotics Market in Canada: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
JAPAN
Table 52: Japanese Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Class for the
Period 2018-2025
Table 53: Antibiotics Market in Japan: Historic Sales Analysis
in US$ Million by Drug Class for the Period 2009-2017
Table 54: Japanese Antibiotics Market Share Analysis by Drug
Class: 2009 VS 2019 VS 2025
Table 55: Japanese Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Origin for the
Period 2018-2025
Table 56: Antibiotics Market in Japan: Historic Sales Analysis
in US$ Million by Drug Origin for the Period 2009-2017
Table 57: Japanese Antibiotics Market Share Analysis by Drug
Origin: 2009 VS 2019 VS 2025
Table 58: Japanese Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Route of
Administration for the Period 2018-2025
Table 59: Antibiotics Market in Japan: Historic Sales Analysis
in US$ Million by Route of Administration for the Period
2009-2017
Table 60: Japanese Antibiotics Market Share Analysis by Route
of Administration: 2009 VS 2019 VS 2025
CHINA
Table 61: Chinese Antibiotics Market Growth Prospects in US$
Million by Drug Class for the Period 2018-2025
Table 62: Antibiotics Historic Market Analysis in China in US$
Million by Drug Class: 2009-2017
Table 63: Chinese Antibiotics Market by Drug Class: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 64: Chinese Antibiotics Market Growth Prospects in US$
Million by Drug Origin for the Period 2018-2025
Table 65: Antibiotics Historic Market Analysis in China in US$
Million by Drug Origin: 2009-2017
Table 66: Chinese Antibiotics Market by Drug Origin: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 67: Chinese Antibiotics Market Growth Prospects in US$
Million by Route of Administration for the Period 2018-2025
Table 68: Antibiotics Historic Market Analysis in China in US$
Million by Route of Administration: 2009-2017
Table 69: Chinese Antibiotics Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
EUROPE
Market Facts & Figures
European Antibiotics Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Table 70: European Antibiotics Market Demand Scenario in US$
Million by Region/Country: 2018-2025
Table 71: Antibiotics Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 72: European Antibiotics Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 73: European Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Class: 2018-2025
Table 74: Antibiotics Market in Europe in US$ Million by Drug
Class: A Historic Review for the Period 2009-2017
Table 75: European Antibiotics Market Share Breakdown by Drug
Class: 2009 VS 2019 VS 2025
Table 76: European Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Origin: 2018-2025
Table 77: Antibiotics Market in Europe in US$ Million by Drug
Origin: A Historic Review for the Period 2009-2017
Table 78: European Antibiotics Market Share Breakdown by Drug
Origin: 2009 VS 2019 VS 2025
Table 79: European Antibiotics Market Estimates and Forecasts
in US$ Million by Route of Administration: 2018-2025
Table 80: Antibiotics Market in Europe in US$ Million by Route
of Administration: A Historic Review for the Period 2009-2017
Table 81: European Antibiotics Market Share Breakdown by Route
of Administration: 2009 VS 2019 VS 2025
FRANCE
Table 82: Antibiotics Market in France by Drug Class: Estimates
and Projections in US$ Million for the Period 2018-2025
Table 83: French Antibiotics Historic Market Scenario in US$
Million by Drug Class: 2009-2017
Table 84: French Antibiotics Market Share Analysis by Drug
Class: 2009 VS 2019 VS 2025
Table 85: Antibiotics Market in France by Drug Origin:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: French Antibiotics Historic Market Scenario in US$
Million by Drug Origin: 2009-2017
Table 87: French Antibiotics Market Share Analysis by Drug
Origin: 2009 VS 2019 VS 2025
Table 88: Antibiotics Market in France by Route of
Administration: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 89: French Antibiotics Historic Market Scenario in US$
Million by Route of Administration: 2009-2017
Table 90: French Antibiotics Market Share Analysis by Route of
Administration: 2009 VS 2019 VS 2025
GERMANY
Table 91: Antibiotics Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Drug Class for the Period
2018-2025
Table 92: German Antibiotics Historic Market Analysis in US$
Million by Drug Class: 2009-2017
Table 93: German Antibiotics Market Share Breakdown by Drug
Class: 2009 VS 2019 VS 2025
Table 94: Antibiotics Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Drug Origin for the
Period 2018-2025
Table 95: German Antibiotics Historic Market Analysis in US$
Million by Drug Origin: 2009-2017
Table 96: German Antibiotics Market Share Breakdown by Drug
Origin: 2009 VS 2019 VS 2025
Table 97: Antibiotics Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Route of Administration
for the Period 2018-2025
Table 98: German Antibiotics Historic Market Analysis in US$
Million by Route of Administration: 2009-2017
Table 99: German Antibiotics Market Share Breakdown by Route of
Administration: 2009 VS 2019 VS 2025
ITALY
Table 100: Italian Antibiotics Market Growth Prospects in US$
Million by Drug Class for the Period 2018-2025
Table 101: Antibiotics Historic Market Analysis in Italy in US$
Million by Drug Class: 2009-2017
Table 102: Italian Antibiotics Market by Drug Class: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 103: Italian Antibiotics Market Growth Prospects in US$
Million by Drug Origin for the Period 2018-2025
Table 104: Antibiotics Historic Market Analysis in Italy in US$
Million by Drug Origin: 2009-2017
Table 105: Italian Antibiotics Market by Drug Origin:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 106: Italian Antibiotics Market Growth Prospects in US$
Million by Route of Administration for the Period 2018-2025
Table 107: Antibiotics Historic Market Analysis in Italy in US$
Million by Route of Administration: 2009-2017
Table 108: Italian Antibiotics Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
UNITED KINGDOM
Table 109: United Kingdom Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Class for the
Period 2018-2025
Table 110: Antibiotics Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 111: United Kingdom Antibiotics Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
Table 112: United Kingdom Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Origin for the
Period 2018-2025
Table 113: Antibiotics Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Drug Origin for the Period
2009-2017
Table 114: United Kingdom Antibiotics Market Share Analysis by
Drug Origin: 2009 VS 2019 VS 2025
Table 115: United Kingdom Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Route of
Administration for the Period 2018-2025
Table 116: Antibiotics Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Route of Administration for
the Period 2009-2017
Table 117: United Kingdom Antibiotics Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
SPAIN
Table 118: Spanish Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Class: 2018 to 2025
Table 119: Spanish Antibiotics Historic Market Review by Drug
Class in US$ Million: 2009-2017
Table 120: Antibiotics Market in Spain: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Table 121: Spanish Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Origin: 2018 to 2025
Table 122: Spanish Antibiotics Historic Market Review by Drug
Origin in US$ Million: 2009-2017
Table 123: Antibiotics Market in Spain: Percentage Share
Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
Table 124: Spanish Antibiotics Market Estimates and Forecasts
in US$ Million by Route of Administration: 2018 to 2025
Table 125: Spanish Antibiotics Historic Market Review by Route
of Administration in US$ Million: 2009-2017
Table 126: Antibiotics Market in Spain: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
RUSSIA
Table 127: Russian Antibiotics Market Estimates and Projections
in US$ Million by Drug Class: 2018 to 2025
Table 128: Antibiotics Market in Russia by Drug Class: A
Historic Review in US$ Million for 2009-2017
Table 129: Russian Antibiotics Market Share Breakdown by Drug
Class: 2009 VS 2019 VS 2025
Table 130: Russian Antibiotics Market Estimates and Projections
in US$ Million by Drug Origin: 2018 to 2025
Table 131: Antibiotics Market in Russia by Drug Origin: A
Historic Review in US$ Million for 2009-2017
Table 132: Russian Antibiotics Market Share Breakdown by Drug
Origin: 2009 VS 2019 VS 2025
Table 133: Russian Antibiotics Market Estimates and Projections
in US$ Million by Route of Administration: 2018 to 2025
Table 134: Antibiotics Market in Russia by Route of
Administration: A Historic Review in US$ Million for 2009-2017
Table 135: Russian Antibiotics Market Share Breakdown by Route
of Administration: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 136: Rest of Europe Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 137: Antibiotics Market in Rest of Europe in US$ Million
by Drug Class: A Historic Review for the Period 2009-2017
Table 138: Rest of Europe Antibiotics Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
Table 139: Rest of Europe Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Origin: 2018-2025
Table 140: Antibiotics Market in Rest of Europe in US$ Million
by Drug Origin: A Historic Review for the Period 2009-2017
Table 141: Rest of Europe Antibiotics Market Share Breakdown by
Drug Origin: 2009 VS 2019 VS 2025
Table 142: Rest of Europe Antibiotics Market Estimates and
Forecasts in US$ Million by Route of Administration: 2018-2025
Table 143: Antibiotics Market in Rest of Europe in US$ Million
by Route of Administration: A Historic Review for the Period
2009-2017
Table 144: Rest of Europe Antibiotics Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 145: Asia-Pacific Antibiotics Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 146: Antibiotics Market in Asia-Pacific: Historic Market
Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 147: Asia-Pacific Antibiotics Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 148: Antibiotics Market in Asia-Pacific by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 149: Asia-Pacific Antibiotics Historic Market Scenario in
US$ Million by Drug Class: 2009-2017
Table 150: Asia-Pacific Antibiotics Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
Table 151: Antibiotics Market in Asia-Pacific by Drug Origin:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 152: Asia-Pacific Antibiotics Historic Market Scenario in
US$ Million by Drug Origin: 2009-2017
Table 153: Asia-Pacific Antibiotics Market Share Analysis by
Drug Origin: 2009 VS 2019 VS 2025
Table 154: Antibiotics Market in Asia-Pacific by Route of
Administration: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 155: Asia-Pacific Antibiotics Historic Market Scenario in
US$ Million by Route of Administration: 2009-2017
Table 156: Asia-Pacific Antibiotics Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
AUSTRALIA
Table 157: Antibiotics Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 158: Australian Antibiotics Historic Market Analysis in
US$ Million by Drug Class: 2009-2017
Table 159: Australian Antibiotics Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
Table 160: Antibiotics Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Drug Origin for
the Period 2018-2025
Table 161: Australian Antibiotics Historic Market Analysis in
US$ Million by Drug Origin: 2009-2017
Table 162: Australian Antibiotics Market Share Breakdown by
Drug Origin: 2009 VS 2019 VS 2025
Table 163: Antibiotics Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Route of
Administration for the Period 2018-2025
Table 164: Australian Antibiotics Historic Market Analysis in
US$ Million by Route of Administration: 2009-2017
Table 165: Australian Antibiotics Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
INDIA
Table 166: Indian Antibiotics Market Estimates and Forecasts in
US$ Million by Drug Class: 2018 to 2025
Table 167: Indian Antibiotics Historic Market Review by Drug
Class in US$ Million: 2009-2017
Table 168: Antibiotics Market in India: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
Table 169: Indian Antibiotics Market Estimates and Forecasts in
US$ Million by Drug Origin: 2018 to 2025
Table 170: Indian Antibiotics Historic Market Review by Drug
Origin in US$ Million: 2009-2017
Table 171: Antibiotics Market in India: Percentage Share
Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
Table 172: Indian Antibiotics Market Estimates and Forecasts in
US$ Million by Route of Administration: 2018 to 2025
Table 173: Indian Antibiotics Historic Market Review by Route
of Administration in US$ Million: 2009-2017
Table 174: Antibiotics Market in India: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
SOUTH KOREA
Table 175: Antibiotics Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 176: South Korean Antibiotics Historic Market Analysis in
US$ Million by Drug Class: 2009-2017
Table 177: Antibiotics Market Share Distribution in South Korea
by Drug Class: 2009 VS 2019 VS 2025
Table 178: Antibiotics Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Drug Origin for
the Period 2018-2025
Table 179: South Korean Antibiotics Historic Market Analysis in
US$ Million by Drug Origin: 2009-2017
Table 180: Antibiotics Market Share Distribution in South Korea
by Drug Origin: 2009 VS 2019 VS 2025
Table 181: Antibiotics Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Route of
Administration for the Period 2018-2025
Table 182: South Korean Antibiotics Historic Market Analysis in
US$ Million by Route of Administration: 2009-2017
Table 183: Antibiotics Market Share Distribution in South Korea
by Route of Administration: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 184: Rest of Asia-Pacific Market for Antibiotics: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 185: Antibiotics Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 186: Rest of Asia-Pacific Antibiotics Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
Table 187: Rest of Asia-Pacific Market for Antibiotics: Annual
Sales Estimates and Projections in US$ Million by Drug Origin
for the Period 2018-2025
Table 188: Antibiotics Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Drug Origin for the Period
2009-2017
Table 189: Rest of Asia-Pacific Antibiotics Market Share
Analysis by Drug Origin: 2009 VS 2019 VS 2025
Table 190: Rest of Asia-Pacific Market for Antibiotics: Annual
Sales Estimates and Projections in US$ Million by Route of
Administration for the Period 2018-2025
Table 191: Antibiotics Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Route of Administration for
the Period 2009-2017
Table 192: Rest of Asia-Pacific Antibiotics Market Share
Analysis by Route of Administration: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 193: Latin American Antibiotics Market Trends by
Region/Country in US$ Million: 2018-2025
Table 194: Antibiotics Market in Latin America in US$ Million
by Region/Country: A Historic Perspective for the Period
2009-2017
Table 195: Latin American Antibiotics Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 196: Latin American Antibiotics Market Growth Prospects
in US$ Million by Drug Class for the Period 2018-2025
Table 197: Antibiotics Historic Market Analysis in Latin
America in US$ Million by Drug Class: 2009-2017
Table 198: Latin American Antibiotics Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 199: Latin American Antibiotics Market Growth Prospects
in US$ Million by Drug Origin for the Period 2018-2025
Table 200: Antibiotics Historic Market Analysis in Latin
America in US$ Million by Drug Origin: 2009-2017
Table 201: Latin American Antibiotics Market by Drug Origin:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 202: Latin American Antibiotics Market Growth Prospects
in US$ Million by Route of Administration for the Period
2018-2025
Table 203: Antibiotics Historic Market Analysis in Latin
America in US$ Million by Route of Administration: 2009-2017
Table 204: Latin American Antibiotics Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
ARGENTINA
Table 205: Argentinean Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 206: Antibiotics Market in Argentina in US$ Million by
Drug Class: A Historic Review for the Period 2009-2017
Table 207: Argentinean Antibiotics Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
Table 208: Argentinean Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Origin: 2018-2025
Table 209: Antibiotics Market in Argentina in US$ Million by
Drug Origin: A Historic Review for the Period 2009-2017
Table 210: Argentinean Antibiotics Market Share Breakdown by
Drug Origin: 2009 VS 2019 VS 2025
Table 211: Argentinean Antibiotics Market Estimates and
Forecasts in US$ Million by Route of Administration: 2018-2025
Table 212: Antibiotics Market in Argentina in US$ Million by
Route of Administration: A Historic Review for the Period
2009-2017
Table 213: Argentinean Antibiotics Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
BRAZIL
Table 214: Antibiotics Market in Brazil by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 215: Brazilian Antibiotics Historic Market Scenario in
US$ Million by Drug Class: 2009-2017
Table 216: Brazilian Antibiotics Market Share Analysis by Drug
Class: 2009 VS 2019 VS 2025
Table 217: Antibiotics Market in Brazil by Drug Origin:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 218: Brazilian Antibiotics Historic Market Scenario in
US$ Million by Drug Origin: 2009-2017
Table 219: Brazilian Antibiotics Market Share Analysis by Drug
Origin: 2009 VS 2019 VS 2025
Table 220: Antibiotics Market in Brazil by Route of
Administration: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 221: Brazilian Antibiotics Historic Market Scenario in
US$ Million by Route of Administration: 2009-2017
Table 222: Brazilian Antibiotics Market Share Analysis by Route
of Administration: 2009 VS 2019 VS 2025
MEXICO
Table 223: Antibiotics Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Drug Class for the Period
2018-2025
Table 224: Mexican Antibiotics Historic Market Analysis in US$
Million by Drug Class: 2009-2017
Table 225: Mexican Antibiotics Market Share Breakdown by Drug
Class: 2009 VS 2019 VS 2025
Table 226: Antibiotics Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Drug Origin for the
Period 2018-2025
Table 227: Mexican Antibiotics Historic Market Analysis in US$
Million by Drug Origin: 2009-2017
Table 228: Mexican Antibiotics Market Share Breakdown by Drug
Origin: 2009 VS 2019 VS 2025
Table 229: Antibiotics Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Route of Administration
for the Period 2018-2025
Table 230: Mexican Antibiotics Historic Market Analysis in US$
Million by Route of Administration: 2009-2017
Table 231: Mexican Antibiotics Market Share Breakdown by Route
of Administration: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 232: Rest of Latin America Antibiotics Market Estimates
and Projections in US$ Million by Drug Class: 2018 to 2025
Table 233: Antibiotics Market in Rest of Latin America by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 234: Rest of Latin America Antibiotics Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
Table 235: Rest of Latin America Antibiotics Market Estimates
and Projections in US$ Million by Drug Origin: 2018 to 2025
Table 236: Antibiotics Market in Rest of Latin America by Drug
Origin: A Historic Review in US$ Million for 2009-2017
Table 237: Rest of Latin America Antibiotics Market Share
Breakdown by Drug Origin: 2009 VS 2019 VS 2025
Table 238: Rest of Latin America Antibiotics Market Estimates
and Projections in US$ Million by Route of Administration: 2018
to 2025
Table 239: Antibiotics Market in Rest of Latin America by Route
of Administration: A Historic Review in US$ Million for
2009-2017
Table 240: Rest of Latin America Antibiotics Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 241: The Middle East Antibiotics Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 242: Antibiotics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 243: The Middle East Antibiotics Market Share Breakdown
by Region/Country: 2009, 2019, and 2025
Table 244: The Middle East Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 245: The Middle East Antibiotics Historic Market by Drug
Class in US$ Million: 2009-2017
Table 246: Antibiotics Market in the Middle East: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and
2025
Table 247: The Middle East Antibiotics Market Estimates and
Forecasts in US$ Million by Drug Origin: 2018 to 2025
Table 248: The Middle East Antibiotics Historic Market by Drug
Origin in US$ Million: 2009-2017
Table 249: Antibiotics Market in the Middle East: Percentage
Share Breakdown of Sales by Drug Origin for 2009, 2019, and
2025
Table 250: The Middle East Antibiotics Market Estimates and
Forecasts in US$ Million by Route of Administration: 2018 to
2025
Table 251: The Middle East Antibiotics Historic Market by
Route of Administration in US$ Million: 2009-2017
Table 252: Antibiotics Market in the Middle East: Percentage
Share Breakdown of Sales by Route of Administration for 2009,
2019, and 2025
IRAN
Table 253: Iranian Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Class for the
Period 2018-2025
Table 254: Antibiotics Market in Iran: Historic Sales Analysis
in US$ Million by Drug Class for the Period 2009-2017
Table 255: Iranian Antibiotics Market Share Analysis by Drug
Class: 2009 VS 2019 VS 2025
Table 256: Iranian Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Drug Origin for the
Period 2018-2025
Table 257: Antibiotics Market in Iran: Historic Sales Analysis
in US$ Million by Drug Origin for the Period 2009-2017
Table 258: Iranian Antibiotics Market Share Analysis by Drug
Origin: 2009 VS 2019 VS 2025
Table 259: Iranian Market for Antibiotics: Annual Sales
Estimates and Projections in US$ Million by Route of
Administration for the Period 2018-2025
Table 260: Antibiotics Market in Iran: Historic Sales Analysis
in US$ Million by Route of Administration for the Period
2009-2017
Table 261: Iranian Antibiotics Market Share Analysis by Route
of Administration: 2009 VS 2019 VS 2025
ISRAEL
Table 262: Israeli Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Class: 2018-2025
Table 263: Antibiotics Market in Israel in US$ Million by Drug
Class: A Historic Review for the Period 2009-2017
Table 264: Israeli Antibiotics Market Share Breakdown by Drug
Class: 2009 VS 2019 VS 2025
Table 265: Israeli Antibiotics Market Estimates and Forecasts
in US$ Million by Drug Origin: 2018-2025
Table 266: Antibiotics Market in Israel in US$ Million by Drug
Origin: A Historic Review for the Period 2009-2017
Table 267: Israeli Antibiotics Market Share Breakdown by Drug
Origin: 2009 VS 2019 VS 2025
Table 268: Israeli Antibiotics Market Estimates and Forecasts
in US$ Million by Route of Administration: 2018-2025
Table 269: Antibiotics Market in Israel in US$ Million by Route
of Administration: A Historic Review for the Period 2009-2017
Table 270: Israeli Antibiotics Market Share Breakdown by Route
of Administration: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 271: Saudi Arabian Antibiotics Market Growth Prospects in

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817707/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001